Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Efthymios Ziogos"'
Autor:
Anum S. Minhas, Thorsten M. Leucker, Erin Goerlich, Alborz Soleimani‐Fard, Michael Schär, Efthymios Ziogos, Eliza Miller, Gary Gerstenblith, Allison G. Hays
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 23 (2022)
Background Impaired coronary endothelial function (CEF) predicts cardiovascular events and occurs in people living with HIV (PLWH). Women compared with men living with HIV have worse cardiovascular outcomes, but prior CEF studies included few women.
Externí odkaz:
https://doaj.org/article/ee14765f9c98427abea82799d5176b95
Autor:
Efthymios Ziogos, Michael A Vavuranakis, Tarek Harb, Palmer L Foran, Michael J Blaha, Steven R Jones, Shenghan Lai, Gary Gerstenblith, Thorsten M Leucker
Publikováno v:
European Heart Journal Open. 3
Aims Lipoprotein(a) [Lp(a)] levels are generally constant throughout an individual’s lifetime, and current guidelines recommend that a single measurement is sufficient to assess the risk of coronary artery disease (CAD). However, it is unclear whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aba735df929ee6f853f0f70529232f1
https://doi.org/10.1093/ehjopen/oead035
https://doi.org/10.1093/ehjopen/oead035
Autor:
Michael A. Vavuranakis, Steven R. Jones, Efthymios Ziogos, Michael J. Blaha, Marlene S. Williams, Palmer Foran, Thomas H. Schindler, Shenghan Lai, Steven P. Schulman, Gary Gerstenblith, Thorsten M. Leucker
Publikováno v:
The American Journal of Cardiology. 171:1-6
Lipoprotein(a), or Lp(a), levels and the effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition on Lp(a) during the peri-infarction and early postinfarction period are not well characterized. This study aimed to describe the traje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a38567246ee4519500a21c868e265a89
https://doi.org/10.1016/j.amjcard.2022.01.058
https://doi.org/10.1016/j.amjcard.2022.01.058
Autor:
Arthur Jason Vaught, Theresa Boyer, Efthymios Ziogos, Nuria Amat-Codina, Anum Minhas, Kristin Darwin, Alexia Debrosse, Neal Fedarko, Irina Burd, Ahmet Baschat, Garima Sharma, Allison G. Hays, Sammy Zakaria, Thorsten M. Leucker
Publikováno v:
Placenta. 132
Preeclampsia is associated with decreased maternal low-density lipoprotein cholesterol (LDL-c), which is essential for fetal growth. The underlying mechanisms for decreased LDL-c in preeclampsia remain unknown. Proprotein convertase subtillisin/kexin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a215a42e303e959252ba3cb539f7870
https://pubmed.ncbi.nlm.nih.gov/36603351
https://pubmed.ncbi.nlm.nih.gov/36603351